DEPRESIJA I TUMORI MOZGA
Sažetak
Depresija je veoma čest komorbiditet kod pacijenata sa tumorom mozga. Bolje razumevanje uzajamnog odnosa između tumora mozga i depresije bi poboljšalo kvalitet života pacijenata sa ovim dijagnozama. Lečenje samih tumora je često povezano sa depresijom. Depresija ima značajan negativan uticaj na ishod bolesti kod pacijenta sa tumorom mozga. Uloga lečenja depresije kod tumora mozga je posebno ispitivana. Mnoge od karakteristika tumora mozga-veličina tumora, lokalizacija, histopatologija se istražuju u vezi sa njihovim mogućim uticajima na depresiju. Dalja istraživanja povezana sa deficitom znanja u ovim oblastima bi trebalo da donesu benefit pacijentima sa moždanim tumorima. Cilj rada je da stvori bolje razumevanje pitanja depresije u populaciji pacijenata sa tumorima mozga. Ovaj cilj je značajan jer je depresija veoma česta komplikacija ili komorbiditet u bolesnika sa tumorima mozga.
Reference
Litofsky NS, Farace E, Anderson F, Meyers CA, Huang W, Laws ER. Glioma Outcomes Project Investigators. Depression in patients with high grade glioma: results of the glioma outcomes project. Neurosurgery 2004; 54: 358–67.
Benson DF, Geschqind N. Psychiatric conditions associated with focal lesions of the central nervous system. In: Arieti S, Freedman DX, Hamburg, eds. American handbook of psychiatry. 2nd edition. New York: Basic Books, 1974.
Cole G. Intracranial space-occupying masses in mental hospital patients: necropsy study. J Neurol Neurosurg Psychiatry 1978; 41: 730–6.
Fischer CE. Experience of electroconvulsive therapy in a case of glioblastoma multiforme. Psychiatry Clin Neurosci 2004; 58: 671.
Kohler CG, Burock M. ECT for psychotic depression associated with a brain tumor. Am J Psychiatry 2001; 158: 2089.
Spence SA, Taylor DG, Hirsch SR. Depressive disorder due to craniopharyngioma. J R Soc Med 1995; 88: 637–8.
Tanaghow A, Lewis J, Jones GH. Anterior tumor of the corpus callosum with atypical depression. Br J Psychiatry 1989; 155: 854–6.
Galasko D, Kwo On Yuen PF, Thal L. Intracranial mass lesions associated with late-onset psychosis and depression. Psychiatr Clin North Am 1988; 11: 151–66.
Moise D, Madhusoodanan S. Psychiatric symptoms associated with brain tumors: a clinical enigma. CNS Spectr 2006; 11: 28–31.
Giovagnoli AR, Silvani A, Colombo E, Boiardi A. Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 2005; 76: 562–8.
Brown PD, Ballman KV, Rummans TA, et al. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol 2006; 76: 283–91.
Mackworth N, Fobair P, Prados MD. Quality of life selfreports from 200 brain tumor patients: comparisons with Karnofsky performance scores. J Neurooncol 1992; 14: 243–53.
Wellish DK, Kaleita TA, Freeman D, Cloughesy T, Goldman J. Predicting major depression in brain tumor patients. Psychooncology 2002; 11: 230–8.
Fox SW, Lyon D, Farace E. Symptom clusters in patients with high-grade glioma. J Nurs Scholarsh 2007; 39: 61–7.
Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P. Depression and functional outcome in patients with brain tumors: a population-based 1-year follow-up study. J Neurosurg 2005; 103: 841–7.
Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol 2002; 57: 41–9.
Kaplan CP, Miner ME. Anxiety and depression in elderly patients receiving treatment for cerebral tumours. Brain Inj 1997; 11: 129–35.
Kaplan CP, Miner ME. Relationships: importance for patients with cerebral tumours. Brain Inj 2000; 14: 251–9.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Association, 2000.
Wen PY. Diagnosis and management of brain tumors. In: Black P McL, Loeffler JS, eds. Cancer of the nervous system. Cambridge: Blackwell Science, 1997: 106-27.
Madhusoodanan S, Danan D, Brenner R, Bogunovic O. Brain tumor and psychiatric manifestations: a case report and brief review. Ann Clin Psychiatry 2004; 16: 111–3.
Filley CM, Kleinschmidt-DeMasters BK. Neurobehavioral presentations of brain neoplasms. West J Med 1951; 163: 19–25.
Stenager EA, Stenager E. Suicide and patients with neurologic diseases. Methodologic problems. Arch Neurol 1992; 49: 1296– 303.
Furgal Borzych A, Lis GJ, Litwin JA, Rzepecka Wozniak E, Trela F, Cichocki T. Increased incidence of pituitary microadenomas in suicide victims. Neuropsychobiology 2007; 55: 163– 6.
Valentine A, Passik S, Massie MJ. Psychiatric and psychosocial issues. In: Levin V, ed. Cancer in the nervous system. 2nd ed.Oxford: Oxford University Press, 2002: 572–89.
Anderson SI, Taylor R. Mood disorders in patients after treatment for primary intracranial tumours. Br J Neurosurg 1999; 13: 480–5.
Takei N, Sugihara G. Diagnostic ambiguity of subthreshold depression: minor depression versus adjustment disorder with depressed mood. Acta Psychiatr Scand 2006; 114: 144.
Cuijpers P, Smith F, van Stralen A. Psychological treatments of subthreshold depression: a meta-analysis review. Acta Psychiatr Scand 2007; 115: 434–41.
Dekkers OM, Biermasz NR, Smit JW, et al. Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol 2006; 154: 483–9.
Stoll T, Kauer Y, Buchi S, Klaghofer R, Sensky T, Villiger PM. Prediction of depression in systemic lupus erythematosus patients using SF-36 mental health scores. Rheumatology 2001; 40: 695–8.
Whooley MA, Avins AL, Miranda J, Browner WS. Casefinding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997; 12: 439–45.
Dekkers OM, van der Klaauw AA, Pereira AM, Biermasz NR, Honkoop PJ, Roelfsema F et al. Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 2006; 91: 3364–9.
Heald AH, Ghosh S, Bray S, et al. Long-term negative impact on quality of life in patients with successfully treated Cushing’s disease. Clin Endocrinol (Oxf) 2004; 61: 458–65.
Pringle AM, Taylor R, Whittle IR. Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 1999; 13: 46–51.
Reavley A, Fisher AD, Owen D, Creed FH, Davis JR. Psychological distress in patients with hyperprolactinemia. Clin Endocrinol (Oxf) 1997; 47: 343–8.
Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P. Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur Psychiatrym 2006; 21: 194–9.
Mainio A, Hakko H, Timonen M, Niemela A, Koivukangas J, Rasanen P. Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery 2005; 56: 1234–41.
Armstrong TS, Mendoza T, Gring I, Coco C, Cohen MZ, Eriksen L et al. Validation of the M.D. Anderson symptom inventory brain tumor module (MDASI-BT). J Neurooncol 2006; 80: 27–35.
Brown PD, Maurer MJ, Rummans TA, et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 2005; 57: 495–504.
Huang ME, Wartella J, Kreutzer J, Broaddus W, Lyckholm L. Functional outcomes and quality of life in patients with brain tumours: a review of the literature. Brain Inj 2001; 15: 843–56.
Armstrong TS, Cohen MZ, Eriksen LR, Hickey JV. Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors. J Nurs Scholarsh 2004; 36: 197–206.
Gathinji M, McGirt MJ, Attenello FJ, Chaichana KL, Than K, Olivi A. Association of preoperative depression and survival after resection of malignant brain astrocytoma. Surg Neurol 2009; 71: 299-303.
Arnold SD, Forman LM, Brigidi BD, et al. Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol 2008; 10: 171–81.
Patkar AA, Hill KP, Weinstein SP, Schwartz SL. ECT in the presence of brain tumor and increased intracranial pressure: evaluation and reduction of risk. J ECT 2000; 16: 189–97.
Uribe VM. Psychiatric symptoms and brain tumor. Am Fam Physician 1986; 34: 95-8.
Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Halperin EC. Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 2003; 55: 992–9.
Gupta RK, Kumar R. Benign brain tumours and psychiatric morbidity: a 5-years retrospective data analysis. Aust N Z J Psychiatry 2004; 38: 316-9.
Steinbach JP, Blaicher HP, Herrlinger U, et al. Surviving glioblastoma for more than 5 years: the patient’s perspective. Neurology 2006; 66: 239–42.
Herrmann M, Curio N, Petz T, et al. Coping with illness after brain diseases-a comparison between patients with malignant brain tumors, stroke, Parkinson’s disease and traumatic brain injury. Disabil Rehabil 2000; 22: 539–46.
Weitzner MA, Kanfer S, Booth-Jones M. Apathy and pituitary disease: it has nothing to do with depression. J Neuropsychiatry Clin Neurosci 2005; 17: 159–66.
Kelly WF. Psychiatric aspects of Cushing’s syndrome. QJM 1996; 89: 543–51.
Pies R. Differential diagnosis of steroid-induced affective disorders. Gen Hosp Psychiatry 1995; 17: 353–61.
Zivkovic N, Berisavac I, Markovic M, et al. Psychiatric manifestations of brain tumors. Materia Medica 2010; 26: 173-6.
Ignjatović Ristić D, Pejović S, Pušičić V. Tri slučaja moždanih tumora sa psihijatrijskim simptomima, XXX Oktobarski zdravstveni dani, Medicinski časopis 2005; 39 (1) Supplement 1